SUMMARY A new specific method for determination of cholecystokinin, CCK-8, and CCK-33, 39 in rat plasma is described. Plasma CCK radioimmunoassay (RIA) is difficult, because of crossreactivity with gastrin. In the rat, problems because ofdifficulties in separating gastrin from CCK by high performance liquid chromatography (HPLC) exist. These were solved by enzyme digestion of gastrin before HPLC separation of molecular variants of CCK from gastrin fragments. Cholecystokinin immunoreactive forms in the HPLC fractions were determined by an antibody, which recognises the carboxyl terminus of CCK and gastrin. Fasting concentrations of small (CCK-8) and large (CCK-33, 39) molecular forms of CCK averaged 1-9 (0 3) pM and were raised to 13-4 (3*8) pM in rats fed ad libitum. Cholecystokinin in lactating rats rose two-fold after suckling, compared with 2-8 fold in response to feeding. The basal ratio between CCK-8 and CCK-33, 39 was -1:1, but increased in favour of CCK-8 after feeding and in response to suckling. Gastrin like immunoreactivity measured in unextracted plasma was found to rise after feeding, but was unchanged in response to suckling.
Cholecystokinin (CCK) gives rise to well known gastrointestinal effects, such as increased pancreatic enzyme secretion, gall bladder contraction and inhibition of gastric emptying.'2 The control of the release of CCK is less well described, however, because of difficulties in measuring CCK in plasma. The major problem with radioimmunoassay (RIA) for CCK, is to obtain CCK specific antibodies that do, not crossreact with gastrin, as the biologically active C-terminal tetrapeptide sequence of CCK is structurally identical to gastrin. The very low plasma concentrations of CCK also demand a highly sensitive RIA. Furthermore, the molecular heterogeneity of CCK and gastrin, with structural dissimilarities between species, cause difficulties in the measurement of CCK. There are several studies of plasma CCK concentrations in dog and man,-' but only few reports on plasma concentrations of CCK in rats as yet.9-"
We have previously presented a method for separate determination of CCK-8 and CCK-33, 39 in dog plasma, based on separation of CCK peptides from gastrin by high performance liquid chromatography (HPLC) before, RIA. '2 This method was shown to be unsuitable for determination of both CCK-8 and CCK-33, 39 in rat plasma, as rat gastrin unlike dog gastrin, did not elute corresponding to human gastrin standards in the HPLC system. Instead, rat gastrin interfered with the determination of CCK. We have therefore developed a specific method for the determination of CCK-8 and CCK-33, 39 in rat plasma, based on enzyme digestion of gastrin before HPLC and consequent RIA detection. In order to measure basal levels, the plasma samples were concentrated 10-fold before radioimmunoassay. 213 Plasma concentrations of CCK are known to increase in response to feeding and various nutrients in the intestine.> In previous studies we have described raised concentrations of CCK not only in response to feeding but also during pregnancy and after suckling in lactating dogs."213 In the present study we have measured circulating concentrations of CCK-8 and CCK-33, 39 in fasted, fed and lactating rats. In addition, plasma concentrations of gastrin like immunoreactivity were determined, since we have previously measured increased plasma concentrations of gastrin in response to suckling in dogs. '3 Methods HIGH PERFORMANCE LIQUID CHROMATOGRAPHY Cholecystokinin and gastrin peptides were separated on a TSK ODS-120 T column (4-6x250 mm, 5 .m particle size, LKB Produkter, Bromma, Sweden) using an isocratic system of 32% acetonitrile in 0-1% trifiuoroacetic acid (TFA)+0. 155 M NaCl with a flow rate of 1 mlmin. This HPLC system resulted in a good separation of CCK-8 and CCK-33, 39, nonsulphated and sulphated gastrin-17 and gastrin-34 ( Fig. 1) . Standards used were sulphated (s) CCK-8, human non-sulphated (ns) gastrin-34, and human non-sulphated and sulphated gastrin-17 (Cambridge Research Biochemicals, Harston, Cambridgeshire, England) and porcine sulphated CCK-33 and CCK-39 (gifts from Professor V Mutt, Stockholm, Sweden). Tissue biopsies of the antrum and duodenum were taken from two rats directly after decapitation. The mucosa was stripped off, immediately put on dry ice and kept frozen until extraction was carried out. Antral mucosa (-0-40 g/rat) was pooled from the two rats and boiled in water (10 ml/g of tissue, pH 6.6) for 10 minutes. Human serum albumin (HSA) 0-1% w/v, was added and the suspension was centrifuged at 2000 rpm for 10 minutes. The supernatant was decanted and divided into two samples before lyophilisation. The duodenal mucosa (-0-2 g/rat) from the two rats was pooled, and first extracted at neutral pH (as described above) and then was 0-1 M HCl (10 mUg of tissue, pH 1.5) added to the insoluble material. 8 The suspension was centrifuged and the supernatant divided into two samples before lyophilisation. One of the duplicate samples from antral and duodenal mucosa, respectively, was enzyme treated with protease from S aureus and then lyophilised before gel filtration.
TREATMENT OF PLASMA SAMPLES Plasma was purified on C18 SEP-PAK cartridges (Waters Associates, Milford, MA, USA). The cartridges were equilibrated with 10 ml 100% acetonitrile (v/v), followed by 10 ml 0 1% acetic acid (v/v) before the application of 2 ml plasma samples. After washing with 5 ml 0-1% acetic acid, the samples were eluted by 6 ml of acetonitrile and 0-1% acetic acid (1:1, v/v) and then lyophilised.
The lyophilised samples were reconstituted in 200 gil of 1% ammonium bicarbonate (w/v, pH 8.0) before a six hour incubation period (370C) with protease from S aureus (5 gig/sample). After the enzyme digestion the samples were again lyophilised.
Enzyme-treated samples were dissolved (500 gil 0-1% TFA and water, 1:1, v/v), filtrated through a Millex-HV filter (Millipore Corporation, Bedford, MA, USA) before loading onto the HPLC column for peptide separation using the system described above. Fractions (0-25 ml) were collected, frozen and lyophilised before analysis by radioimmunoassay.
The lyophilised samples were reconstituted in In two groups of rats, pups were returned to their mothers. In one of the groups, lactating rats were decapitated two minutes after start of suckling and in the other group after -10 min of suckling when milkejection occurred, as indicated by a characteristic behaviour, the stretch reaction. A separate group of rats was offered food pellets and was allowed to eat for two minutes before decapitation. Control rats were decapitated after the fasting and separation period.
COLLECTION OF SAMPLES
Trunk blood (-5 ml) was collected in ice chilled tubes containing 10 IU heparin/ml (Kabi AB, Stockholm, Sweden) and 500 IU aprotinin/mI (Bayer AB, Stockholm, Sweden). The samples were immediately centrifuged and plasma stored at -20°C until assayed for CCK and gastrin. Gel chromatography of antral extract produced two peaks of gastrin immunoreactivity. One peak eluted in the same area as gastrin-34 and the other peak eluted in correspondence with gastrin-17 (Fig. 4a) . The gel filtration pattern of duodenal extract revealed the presence of two or three CCK immunoreactive peaks, which eluted in the same area as CCK-39 and CCK-33 (which coelute) and corresponding to CCK-8 (Fig. Sa) .
Gel chromatography of enzyme treated antral extract revealed a completely changed elution pattern, whereas the gel filtration pattern of duo- When rat gastrin-17 and -34 obtained after gel filtration of antral mucosa were applied to the HPLC column, it was shown that the elution positions did not correspond to the respective human gastrin standards, since rat gastrin eluted considerably earlier in fractions that also contain CCK (Fig. 6a) . Cholecystokinin immunoreactive material obtained after gel filtration of rat duodenal extract corresponding to standards of CCK-8 and CCK-33, 39, however, was shown to coelute with the CCK standards on the HPLC column (Fig. 6b) Figs 7a and 7b , respectively. In the enzymetreated plasma sample, immunoreactive material was found with the carboxyl terminal assay, but not with the gastrin specific assay in fractions corresponding to exogenous CCK-8 (elution time 9S5-10.5 min) and CCK-33 and -39 (which coelute, elution time 6.25-7-25 min). These fractions are therefore considered to contain rat CCK. This is in contrast with the nontreated plasma sample, which contained gastrin specific immunoreactivity in the fractions for CCK-8 and CCK-33, 39. Furthermore, in the enzymetreated plasma sample immunoreactivity was found with the carboxyl-terminal assay and the gastrin specific assay in fractions corresponding to Cterminal fragments of non-sulphated and sulphated Gastrin Gastrin concentrations averaged 51 (4-1) pM in fasted control rats and were significantly raised (p<0O01) to 120 (12.6) pM in fed control rats. Gastrin concentrations in the group of fasted vagotomised rats were 83 (7.3) pM, which is significantly higher (p<O.O5) than in the group of fasted control rats. In the group of fed vagotomised rats, gastrin concentrations averaged 63 (4-5) pM. mental groups compared with CCK concentrations in the control group. The ratio CCK-8/CCK-33, 39 was in favour of CCK-33, 39 in the control group but was significantly changed (p<0.05) to be increased in favour of CCK-8 in the fed group and with the same tendency in the suckling group (p=006). Fig. 9a HPLC system. Instead, rat gastrin eluted much earlier in fractions also containing CCK. It has previously been shown that rat gastrin differs from other mammalian gastrins in certain physical and chemical properties.'92' Thus, rat gastrin-17 elutes before human and porcine gastrin-17 from Sephadex G 50 columns, and it elutes earlier than human gastrin-17 from anion exchange columns. Furthermore, rat gastrin-17 has poor immunoreactivity with antibodies specific for the N-terminal region of human of porcine gastrin-17 but good immunoreactivity with antibodies specific for the C-terminal region of gastrin-17. The different behaviours of rat gastrin as described above can be explained by the amino acid sequence for rat gastrin, which substantially differs from that of other species at the amino terminus of gastrin-17. The sequence, Gln-Gly-Pro-Trp described for all other gastrins sequenced"' is Gln-Arg-Pro-Pro in rat gastrin.7"" This variance is probably the reason for the different elution positions of rat gastrin compared to human gastrin standards in chromatographic systems.
We solved the problem of incomplete separation of CCK from gastrin in our HPLC system by using an enzyme which cleaves gastrin but not CCK, before HPLC separation and RIA detection. The enzyme is a protease from Staphylococcus aureus V. 8 Cholecystokinin was found to be released in response to suckling in lactating rats, which is in accordance with previous data in dogs.'3 The ratio CCK-8/CCK-33, 39 was in favour of the larger forms in control samples but was changed in favour of CCK-8 in suckling samples. Thus, a tendency of CCK-8 predominance is seen after both feeding and suckling. Plasma concentrations of gastrin were not significantly increased in response to suckling, which is in contrast with previous findings in dogs.'1 We have previously hypothesised that suckling induces a reflex activation of the vagal nerve, which leads to a release of several gastrointestinal hormones such as insulin, gastrin, and CCK in lactating animals.'311 As CCK can be released in response to vagal stimulation,-" raised plasma concentrations of CCK after suckling may be caused by such an activation of the vagal nerve.
In conclusion, the present study shows a new and specific method for determination of CCK-8 and CCK-33, 39 in rat plasma, based on enzyme digestion of gastrin before HPLC separation and detection by a carboxyl-terminal assay. By this method we have measured raised plasma concentrations of CCK in response to physiological stimuli such as feeding and suckling in lactating rats.
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